Return On Assets of Evofem Biosciences, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Evofem Biosciences, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • Evofem Biosciences, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -34%, a 46% increase year-over-year.
  • Evofem Biosciences, Inc. annual Return On Assets for 2024 was -55%, a 117% decline from 2023.
  • Evofem Biosciences, Inc. annual Return On Assets for 2023 was 331%.
  • Evofem Biosciences, Inc. annual Return On Assets for 2022 was -197%, a 25% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Evofem Biosciences, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -34% +28% +46% 01 Jul 2025 30 Sep 2025
Q2 2025 -33% -628% -106% 01 Apr 2025 30 Jun 2025
Q1 2025 -18% -456% -104% 01 Jan 2025 31 Mar 2025
Q4 2024 -55% -386% -117% 01 Oct 2024 31 Dec 2024
Q3 2024 -62% -300% -126% 01 Jul 2024 30 Sep 2024
Q2 2024 595% +333% +128% 01 Apr 2024 30 Jun 2024
Q1 2024 438% +566% 01 Jan 2024 31 Mar 2024
Q4 2023 331% +529% 01 Oct 2023 31 Dec 2023
Q3 2023 238% +515% 01 Jul 2023 30 Sep 2023
Q2 2023 261% +834% 01 Apr 2023 30 Jun 2023
Q1 2023 -128% +173% +57% 01 Jan 2023 31 Mar 2023
Q4 2022 -197% +66% +25% 01 Oct 2022 31 Dec 2022
Q3 2022 -278% -73% -36% 01 Jul 2022 30 Sep 2022
Q2 2022 -573% -431% -305% 01 Apr 2022 30 Jun 2022
Q1 2022 -302% -151% -101% 01 Jan 2022 31 Mar 2022
Q4 2021 -263% -110% -72% 01 Oct 2021 31 Dec 2021
Q3 2021 -205% -48% -30% 01 Jul 2021 30 Sep 2021
Q2 2021 -141% +39% +22% 01 Apr 2021 30 Jun 2021
Q1 2021 -150% +86% +36% 01 Jan 2021 31 Mar 2021
Q4 2020 -153% +104% +40% 01 Oct 2020 31 Dec 2020
Q3 2020 -157% +170% +52% 01 Jul 2020 30 Sep 2020
Q2 2020 -180% +273% +60% 01 Apr 2020 30 Jun 2020
Q1 2020 -236% +381% +62% 01 Jan 2020 31 Mar 2020
Q4 2019 -256% +672% +72% 01 Oct 2019 31 Dec 2019
Q3 2019 -327% +635% +66% 01 Jul 2019 30 Sep 2019
Q2 2019 -453% +1185% +72% 01 Apr 2019 30 Jun 2019
Q1 2019 -617% +1851% +75% 01 Jan 2019 31 Mar 2019
Q4 2018 -928% +517% +36% 01 Oct 2018 31 Dec 2018
Q3 2018 -962% +49% +4.9% 01 Jul 2018 30 Sep 2018
Q2 2018 -1639% -1148% -234% 01 Apr 2018 30 Jun 2018
Q1 2018 -2468% -2088% -549% 01 Jan 2018 31 Mar 2018
Q4 2017 -1445% -1096% -314% 01 Oct 2017 31 Dec 2017
Q3 2017 -1011% -767% -315% 01 Jul 2017 30 Sep 2017
Q2 2017 -490% -357% -268% 01 Apr 2017 30 Jun 2017
Q1 2017 -381% -272% -251% 01 Jan 2017 31 Mar 2017
Q4 2016 -349% -274% -363% 01 Oct 2016 31 Dec 2016
Q3 2016 -244% -189% -344% 01 Jul 2016 30 Sep 2016
Q2 2016 -133% 01 Apr 2016 30 Jun 2016
Q1 2016 -108% 01 Jan 2016 31 Mar 2016
Q4 2015 -75% 01 Oct 2015 31 Dec 2015
Q3 2015 -55% 01 Jul 2015 30 Sep 2015

Evofem Biosciences, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -55% -386% -117% 01 Jan 2024 31 Dec 2024
2023 331% +529% 01 Jan 2023 31 Dec 2023
2022 -197% +66% +25% 01 Jan 2022 31 Dec 2022
2021 -263% -110% -72% 01 Jan 2021 31 Dec 2021
2020 -153% +104% +40% 01 Jan 2020 31 Dec 2020
2019 -256% +672% +72% 01 Jan 2019 31 Dec 2019
2018 -928% +517% +36% 01 Jan 2018 31 Dec 2018
2017 -1445% -1102% -321% 01 Jan 2017 31 Dec 2017
2016 -343% -268% -355% 01 Jan 2016 31 Dec 2016
2015 -75% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.